International Stroke Conference 2025  /  Clinical Translation of Randomized Trials: Challenges, Opportunities, and the Importance Of Designing Trials With Patient And Community Engagement for Implementability  /  Patient and other Stakeholders’ Participation in Secondary Prevention Design
Logo

American Heart Association

  7
  0

Final ID:

Patient and other Stakeholders’ Participation in Secondary Prevention Design

  • Bushnell, Cheryl  ( WAKE FOREST UNIV HEALTH SCIENCES , Winston Salem , North Carolina , United States )
    • Author Disclosures:
    Cheryl Bushnell: DO have relevant financial relationships ; Ownership Interest:Care Directions, LLC:Active (exists now)
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Clinical Translation of Randomized Trials: Challenges, Opportunities, and the Importance Of Designing Trials With Patient And Community Engagement for Implementability

Thursday, 02/06/2025 , 03:30PM - 04:30PM

ISC Invited Symposium

More abstracts on this topic:
Patient and other Stakeholders’ Engagement in Acute Stroke Research

Mistry Eva, Field Thalia

Designing Trials to Consider Patient and Stakeholder Engagement in Stroke Rehabilitation Research

Cramer Steven, Cadilhac Dominique, Cameron Jan

More abstracts from these authors:
Guideline Overview and Implications for Practice

Bushnell Cheryl

AHA 2024 Guideline on Primary Prevention of Ischemic Stroke

Bushnell Cheryl, Sharrief Anjail

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)